As the PEPFAR program approaches its two-decade mark and begins the process of developing the next five-year strategy, this new analysis finds the program was associated with large declines in mortality in PEPFAR recipient countries since its creation in 2003, suggesting that future investments will continue to yield significant health impacts.
- view as grid
- view as list
This brief explores key issues and poses questions regarding PEPFAR’s future, providing a roadmap for the major decisions ahead for the program. It identifies eight key, interrelated issues facing the administration, Congress, and other PEPFAR stakeholders.
This dashboard monitors progress being made to address the HIV/AIDS epidemic in countries where PEPFAR operates. It includes data for 53 countries, including 13 PEPFAR high-burden countries, and tracks progress against 6 different indicators.
KFF/UNAIDS Analysis Finds That While Donor Government Spending on HIV Increased in 2020, Future Funding is Uncertain with COVID-19 Challenges
A new report from KFF (Kaiser Family Foundation) and The Joint United Nations Programme on HIV/AIDS (UNAIDS) finds that donor government disbursements to combat HIV in low- and middle-income countries increased by US$377 million in 2020, reaching US$8.2 billion in 2020 compared to US$7.8 billion in 2019. Donor government funding…
This report from KFF and The Joint United Nations Programme on HIV/AIDS (UNAIDS) finds donor government disbursements to combat HIV in low- and middle-income countries totaled US$7.8 billion in 2019, a reduction from the US$8 Billion in 2018 and nearly the same as the funding levels of a decade ago.
Recent and Anticipated Actions to Reverse Trump Administration Section 1557 Non-Discrimination Rules
The Biden Administration has started taking steps to reverse Trump Administration policy and regulations that significantly narrowed the implementation and administrative enforcement of Section 1557, the Affordable Care Act’s nondiscrimination provision, particularly as the regulations apply to gender identity and sexual orientation. In addition, several lawsuits challenging the regulations, which…
This data note provides a topline overview of the Biden administration’s fiscal year 2022 Domestic HIV Budget Request to Congress and includes comparisons to fiscak year 2021 funding levels.
This brief examines and summarizes what we know about COVID-19 and HIV including, what we know about COVID-19 risk, disease severity, vaccination, and federal response. It also explores how people with HIV are overly represented in many of the demographic groups hardest hit by the pandemic.
This tracker provides regularly updated information on U.S. government funding for global health. It includes historical trends and tracks funding levels throughout the appropriations process. Data can be customized by fiscal year, sector, and U.S. agency.
This updated fact sheet provides the latest data on the global HIV/AIDS epidemic, including impact by region, treatment and prevention efforts, and an overview of the U.S. and global responses to the epidemic.